These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 231639)

  • 21. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
    Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
    Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
    [No Abstract]   [Full Text] [Related]  

  • 22. [Influence of sodium alginate on the intestinal transit in low birth weight newborn infants].
    Chouraqui JP; Morer I; Renard P; Bielsky MC; Richard-Berthe C; Rambaud P
    Pediatrie; 1993; 48(6):473-7. PubMed ID: 8247649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment with sodium alginate of gastroesophageal reflux disease in childhood: efficacy and tolerance assessment].
    Maestri L
    Pediatr Med Chir; 2001; 23(3-4):187-9. PubMed ID: 11723856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children.
    Buts JP; Barudi C; Otte JB
    Eur J Pediatr; 1987 Mar; 146(2):156-8. PubMed ID: 3032640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2008; (6):77-81. PubMed ID: 19334430
    [No Abstract]   [Full Text] [Related]  

  • 26. Gastric pH and endoscopic appearance after Algicon administration.
    Lambert JR; Korman MG; Nicholson L
    Br J Clin Pract Suppl; 1989 Feb; 66():25-8; discussion 35-6. PubMed ID: 2511920
    [No Abstract]   [Full Text] [Related]  

  • 27. [Update on gastroesophageal reflux disease].
    Serra Pueyo J
    Gastroenterol Hepatol; 2014 Feb; 37(2):73-82. PubMed ID: 24355558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
    Corvaglia L; Aceti A; Mariani E; De Giorgi M; Capretti MG; Faldella G
    Aliment Pharmacol Ther; 2011 Feb; 33(4):466-70. PubMed ID: 21158879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The alginate raft: a scintigraphic evaluation.
    McKay AP; Wraight EP; Hunter JO
    Br J Clin Pract Suppl; 1989 Feb; 66():20-4; discussion 35-6. PubMed ID: 2511919
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gastroesophageal reflux disease during pregnancy].
    Elokhina TB; Tiutiunnik VL
    Eksp Klin Gastroenterol; 2009; (3):93-7. PubMed ID: 19928006
    [No Abstract]   [Full Text] [Related]  

  • 31. [Can acid pocket-targeting alginate-antacid (Gaviscon Double Action) relieve upper gastrointestinal symptoms in gastro-oesophageal reflux disease?].
    Kim SE; Park MI
    Korean J Gastroenterol; 2014 Jun; 63(6):386-8. PubMed ID: 25097964
    [No Abstract]   [Full Text] [Related]  

  • 32. [Multicenter study of sodium alginate in the treatment of regurgitation in infants].
    Le Luyer B; Mougenot JF; Mashako L; Chapoy P; Olives JP; Morali A; Chevallier B; Ginies JL; Dupont C; Dagorne M
    Ann Pediatr (Paris); 1992 Dec; 39(10):635-40. PubMed ID: 1485782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A successful treatment of gastro-oesophageal reflux in infancy with Gaviscon].
    Gross-Kieselstein E; Branski D; Abrahamov A
    Harefuah; 1975 Oct; 89(7):327-9. PubMed ID: 171200
    [No Abstract]   [Full Text] [Related]  

  • 34. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
    Onuchina EV; Brikova SI; Tsukanov VV
    Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension.
    Washington N; Greaves JL; Iftikhar SY
    Aliment Pharmacol Ther; 1992 Oct; 6(5):579-88. PubMed ID: 1420749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oesophageal disease in the elderly.
    Pelemans W; Vantrappen G
    Clin Gastroenterol; 1985 Oct; 14(4):635-56. PubMed ID: 2867841
    [No Abstract]   [Full Text] [Related]  

  • 38. Commentary: revisiting the past--does it hold the key to the future treatment of refractory GERD?
    Katz PO; Schnoll-Sussman F
    Aliment Pharmacol Ther; 2013 Jul; 38(2):202-3. PubMed ID: 23772900
    [No Abstract]   [Full Text] [Related]  

  • 39. Oesophagitis and the role of antacid therapy.
    Rhodes J
    Scand J Gastroenterol Suppl; 1982; 75():74-6. PubMed ID: 6959253
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
    Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
    Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.